Walgreens Boots Alliance, Inc. (NASDAQ:WBA) Shares Sold by Brown Lisle Cummings Inc.

Brown Lisle Cummings Inc. lowered its position in Walgreens Boots Alliance, Inc. (NASDAQ:WBAFree Report) by 30.9% during the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 19,402 shares of the pharmacy operator’s stock after selling 8,680 shares during the quarter. Brown Lisle Cummings Inc.’s holdings in Walgreens Boots Alliance were worth $181,000 at the end of the most recent quarter.

Other institutional investors and hedge funds also recently added to or reduced their stakes in the company. Greenleaf Trust grew its position in shares of Walgreens Boots Alliance by 52.9% during the fourth quarter. Greenleaf Trust now owns 15,738 shares of the pharmacy operator’s stock worth $147,000 after buying an additional 5,447 shares in the last quarter. Tokio Marine Asset Management Co. Ltd. boosted its stake in Walgreens Boots Alliance by 21.0% during the 4th quarter. Tokio Marine Asset Management Co. Ltd. now owns 30,677 shares of the pharmacy operator’s stock valued at $286,000 after acquiring an additional 5,334 shares during the last quarter. Independence Bank of Kentucky acquired a new position in Walgreens Boots Alliance during the 4th quarter worth $39,000. Caprock Group LLC bought a new stake in shares of Walgreens Boots Alliance in the 4th quarter worth about $108,000. Finally, Murphy Pohlad Asset Management LLC acquired a new stake in shares of Walgreens Boots Alliance in the 4th quarter valued at about $413,000. 58.59% of the stock is owned by hedge funds and other institutional investors.

Wall Street Analysts Forecast Growth

Several analysts recently weighed in on the company. Evercore ISI boosted their price objective on Walgreens Boots Alliance from $9.00 to $12.00 and gave the company an “in-line” rating in a report on Monday, January 13th. Bank of America boosted their price target on Walgreens Boots Alliance from $7.50 to $8.50 and gave the company an “underperform” rating in a report on Monday, January 13th. Morgan Stanley decreased their price objective on shares of Walgreens Boots Alliance from $9.00 to $7.00 and set an “underweight” rating for the company in a report on Friday, October 11th. Jefferies Financial Group lowered their target price on shares of Walgreens Boots Alliance from $19.00 to $9.00 and set a “hold” rating for the company in a research note on Wednesday, October 23rd. Finally, Barclays raised their price target on shares of Walgreens Boots Alliance from $7.00 to $8.00 and gave the stock an “underweight” rating in a research report on Wednesday, October 16th. Four analysts have rated the stock with a sell rating, nine have given a hold rating and two have assigned a buy rating to the company’s stock. Based on data from MarketBeat.com, the company currently has an average rating of “Hold” and a consensus price target of $13.19.

View Our Latest Stock Analysis on WBA

Walgreens Boots Alliance Stock Performance

WBA opened at $9.89 on Wednesday. Walgreens Boots Alliance, Inc. has a twelve month low of $8.08 and a twelve month high of $23.76. The business’s 50 day moving average is $10.13 and its 200-day moving average is $9.83. The company has a quick ratio of 0.30, a current ratio of 0.64 and a debt-to-equity ratio of 0.68.

Walgreens Boots Alliance (NASDAQ:WBAGet Free Report) last released its quarterly earnings results on Friday, January 10th. The pharmacy operator reported $0.51 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.38 by $0.13. Walgreens Boots Alliance had a positive return on equity of 17.61% and a negative net margin of 5.87%. The company had revenue of $39.50 billion during the quarter, compared to analysts’ expectations of $37.40 billion. During the same quarter in the prior year, the business posted $0.66 earnings per share. The company’s revenue for the quarter was up 7.6% compared to the same quarter last year. Equities research analysts expect that Walgreens Boots Alliance, Inc. will post 1.6 earnings per share for the current year.

Walgreens Boots Alliance Company Profile

(Free Report)

Walgreens Boots Alliance, Inc operates as a healthcare, pharmacy, and retail company in the United States, the United Kingdom, Germany, and internationally. It operates through three segments: U.S. Retail Pharmacy, International, and U.S. Healthcare. The U.S. Retail Pharmacy segment engages in operation of the retail drugstores, health and wellness services, specialty, and home delivery pharmacy services, which offers health and wellness, beauty, personal care and consumables, and general merchandise.

See Also

Want to see what other hedge funds are holding WBA? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Walgreens Boots Alliance, Inc. (NASDAQ:WBAFree Report).

Institutional Ownership by Quarter for Walgreens Boots Alliance (NASDAQ:WBA)

Receive News & Ratings for Walgreens Boots Alliance Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Walgreens Boots Alliance and related companies with MarketBeat.com's FREE daily email newsletter.